West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
222.20
-3.86 (-1.71%)
At close: Mar 28, 2025, 4:00 PM
219.12
-3.08 (-1.39%)
After-hours: Mar 28, 2025, 8:00 PM EDT
WST Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for WST stock have an average target of 349, with a low estimate of 275 and a high estimate of 400. The average target predicts an increase of 57.07% from the current stock price of 222.20.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for WST stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 3 | 3 |
| Buy | 2 | 2 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $275 | Buy | Initiates | $275 | +23.76% | Mar 18, 2025 |
| Keybanc | Keybanc | Buy Maintains $470 → $325 | Buy | Maintains | $470 → $325 | +46.26% | Feb 14, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +80.02% | Jan 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $350 → $355 | Strong Buy | Maintains | $350 → $355 | +59.77% | Dec 13, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 13, 2024 |
Financial Forecast
Revenue This Year
2.92B
from 2.89B
Increased by 0.93%
Revenue Next Year
3.12B
from 2.92B
Increased by 6.68%
EPS This Year
6.26
from 6.69
Decreased by -6.41%
EPS Next Year
7.26
from 6.26
Increased by 15.91%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.0B | 3.3B | 3.5B | ||
| Avg | 2.9B | 3.1B | 3.3B | ||
| Low | 2.8B | 2.9B | 3.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.3% | 13.9% | 13.3% | ||
| Avg | 0.9% | 6.7% | 6.5% | ||
| Low | -2.5% | 0.2% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.10 | 9.82 | 8.79 | ||
| Avg | 6.26 | 7.26 | 7.85 | ||
| Low | 5.69 | 6.43 | 7.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0% | 56.8% | 21.1% | ||
| Avg | -6.4% | 15.9% | 8.2% | ||
| Low | -14.9% | 2.7% | -3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.